On June 23, IBSA unconditionally supported the drug falsification webinar.
The event was attended by some of the leading experts in the field of health, to provide an updated and in-depth contribution on the subject of drug counterfeiting from the point of view of the clinician, endocrinologist, general practitioner and pharmacist.
The World Health Organization (WHO) defines as falsified "Medicinal products that deliberately and fraudulently present a false indication of their identity, composition or origin".
Doctor Monica Bartolomei, Senior Researcher of the Istituto Superiore Sanità, highlighted how falsified medicines are never equivalent in quality, safety and efficacy to the corresponding original medicines and their production can take place in unsuitable environments or not respecting the Good Manufacturing Practices (GMP) used by the pharmaceutical industry.
From the webinar revealed that the falsification of drugs is a tangible and rapidly growing problem, which needs immediate action to raise awareness among citizens about this illegal and dangerous practice for health.